Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Volume 18 - Issue 6 - June 2021

Insights

Interview
Advanced Stroke Imaging in the Emergency Room: Saving Precious Time and Improving Patient Outcomes
06/29/2021
VDM speaks with neurointerventional surgeon Ryan A. McTaggart, MD, on the unique clinical pathway for stroke patients at Rhode Island Hospital, in Providence, Rhode Island.
VDM speaks with neurointerventional surgeon Ryan A. McTaggart, MD, on the unique clinical pathway for stroke patients at Rhode Island Hospital, in Providence, Rhode Island.
VDM speaks with...
06/29/2021
Vascular Disease Management
Editorial/Commentary
Proper Shielding Technique in Protecting Against Scatter Radiation
06/11/2021
Radiation shielding can provide effective protection from scatter radiation during vascular angiographic procedures.
Radiation shielding can provide effective protection from scatter radiation during vascular angiographic procedures.
Radiation shielding can provide...
06/11/2021
Vascular Disease Management

Feature

OBL Corner
Disaster Preparedness in the OBL
06/29/2021
Managing the impact of a natural disaster on an OBL is difficult. The lessons learned from our experience in surviving direct hits from two hurricanes may be of value to others.
Managing the impact of a natural disaster on an OBL is difficult. The lessons learned from our experience in surviving direct hits from two hurricanes may be of value to others.
Managing the impact of a natural...
06/29/2021
Vascular Disease Management
Original Contribution
A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy
06/11/2021
The primary objective of this study was to evaluate the clinical success of peripheral orbital atherectomy procedures with transradial access.
The primary objective of this study was to evaluate the clinical success of peripheral orbital atherectomy procedures with transradial access.
The primary objective of this...
06/11/2021
Vascular Disease Management
Review
Review of Embolic Protection Devices in Percutaneous Peripheral Intervention
06/11/2021
This review discusses the current data available for debris burden of different atherectomy devices and efficacy of infrainguinal embolic protection devices.
This review discusses the current data available for debris burden of different atherectomy devices and efficacy of infrainguinal embolic protection devices.
This review discusses the...
06/11/2021
Vascular Disease Management

Column

Editor's Corner
The Increasing Use of Transradial Approach for Peripheral Interventions
06/11/2021
Craig Walker, MD, discusses Ansaarie et al’s article, “A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy.”
Craig Walker, MD, discusses Ansaarie et al’s article, “A Retrospective Cohort Study to Evaluate the Efficacy and Safety of Minimal Arterial Access Lower-Extremity Intervention Via Peripheral Orbital Atherectomy.”
Craig Walker, MD, discusses...
06/11/2021
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

June 2021 Volume 18 Issue 6

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement